Skip to content

Tooru Kamata

Osaka Prefectural Police Department

3 papers in the library · 105 citations · publishing 2003-2007

Papers

Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples

Journal of Chromatography B October 14, 2003 Tooru Kamata, Mayumi Nishikawa, Munehiro Katagi et al. 65 citations

A sensitive analytical method for detecting psilocin in urine was developed by optimizing hydrolysis conditions. Enzymatic hydrolysis using Escherichia coli beta-glucuronidase (5000 units/ml urine) at pH 6 and 37°C for 2 hours completely converted psilocin glucuronide to psilocin, whereas enzymes from bovine liver, Helix pomatia, and Ampullaria gave incomplete conversion. Acid and alkaline hydrolysis were not applicable. In a magic mushroom user's urine, 3.55 µg/ml of psilocin was detected after enzymatic hydrolysis, but none without hydrolysis.

Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user

Forensic Toxicology June 15, 2006 Tooru Kamata, Mayumi Nishikawa, Munehiro Katagi et al. 36 citations

In a groundbreaking investigation, 70% of urine samples from participants who ingested psilocybin mushrooms showed the presence of specific glucuronide metabolites. Utilizing advanced chromatography and mass spectrometry techniques, the study highlighted how these metabolites influence neurotransmitter receptors, potentially affecting behavior. This work enhances forensic toxicology and drug analysis, providing crucial insights into the chemistry of psychedelics. The findings underscore the importance of understanding metabolic pathways, as glucuronidase activity plays a key role in how substances are processed in the body.

Urinary Excretion Profiles of 5-Methoxy-N,N-diisopropyltryptamine and Its Relevant Metabolites in Humans

JOURNAL OF HEALTH SCIENCE January 1, 2007 Tooru Kamata, Munehiro Katagi, Hiroe Kamata et al. 4 citations

In urine from six users of the psychedelic tryptamine 5-MeO-DIPT, three metabolites—5-OH-DIPT, 6-OH-5-MeO-DIPT, and 5-MeO-NIPT—were identified. Using enzymatic hydrolysis with ascorbic acid to prevent degradation, conjugated forms (sulfates and glucuronides) of the hydroxylated metabolites were fully cleaved, greatly increasing their detection, especially for 6-OH-5-MeO-DIPT. After hydrolysis, concentrations of 5-OH-DIPT ranged from 0.01 to 47 μg/ml and 6-OH-5-MeO-DIPT up to 69 μg/ml, while the parent drug and 5-MeO-NIPT remained below 1.7 and 3.5 μg/ml, respectively. Metabolites were detectable longer than the parent compound: 5-OH-DIPT up to 80 hours, 6-OH-5-MeO-DIPT and 5-MeO-NIPT up to 60 hours, versus 35 hours for 5-MeO-DIPT.